Search results

Publication date Communities Collections Article title Author(s)
7 Jan 2020 BMRC Bioprocessing Technology Institute Preclinical Activity of Embryonic Annexin A2-Specific Chimeric Antigen Receptor T Cells Against Ovarian Cancer Leonard Leong, Heng Liang Tan, Simeon Cua, Kylie Su Mei Yong, Qingfeng Chen, Andre Choo
15 Nov 2019 BMRC Bioprocessing Technology Institute Opportunities for Antibody Discovery Using Human Pluripotent Stem Cells: Conservation of Oncofetal Targets Heng Liang Tan, Andre Choo
7 Aug 2019 BMRC Bioprocessing Technology Institute In vivo surveillance and elimination of teratoma‐forming human embryonic stem cells with monoclonal antibody 2448 targeting annexin A2 Heng Liang Tan, Bao Zhu Tan, Winfred Xi Tai Goh, Simeon Cua, Andre Choo
2 Aug 2018 BMRC Bioprocessing Technology Institute Conservation of oncofetal antigens on human embryonic stem cells enables discovery of monoclonal antibodies against cancer Heng Liang Tan, Charlene Yong, Bao Zhu Tan, Wey Jia Fong, Jayanthi Padmanabhan, Angela Chin, Vanessa Ding, Ally Lau, Lu Zheng, Xuezhi Bi, Yuansheng Yang, Andre Choo
10 Jan 2018 BMRC Bioprocessing Technology Institute Targeting of embryonic annexin A2 expressed on ovarian and breast cancer by the novel monoclonal antibody 2448 Simeon Cua, Heng Liang Tan, Wey Jia Fong, Angela Chin, Ally Lau, Vanessa Ding, Zhiwei Song, Yuansheng Yang, Andre Choo
30 Apr 2009 BMRC Bioprocessing Technology Institute mAb 84, a Cytotoxic Antibody that Kills Undifferentiated Human Embryonic Stem Cells via Oncosis Heng Liang Tan, Wey Jia Fong, Eng Hin Lee, Miranda Yap, Andre Choo